Funder: Ionis Pharmaceuticals

Due Dates: Rolling (applications must be submitted at least 60 days before program start date)

Funding Amounts: No fixed limits; award size and duration vary by project and available resources; funding is not guaranteed.

Summary: Supports independent, evidence-based medical education programs in hereditary angioedema (HAE) and severe hypertriglyceridemia (sHTG).

Key Information: Programs must be independent, unbiased, and free of industry influence; no support for ATTR topics.